What is the projected market valuation of the Endoscopic Submucosal Dissection Market by 2035?

The projected market valuation for the Endoscopic Submucosal Dissection Market is expected to reach approximately 0.8998 USD Billion by 2035. Read More

What was the market valuation of the Endoscopic Submucosal Dissection Market in 2024?

The overall market valuation for the Endoscopic Submucosal Dissection Market was 0.42 USD Billion in 2024. Read More

What is the expected CAGR for the Endoscopic Submucosal Dissection Market during the forecast period 2025 - 2035?

The expected CAGR for the Endoscopic Submucosal Dissection Market during the forecast period 2025 - 2035 is 7.17%. Read More

Which companies are considered key players in the Endoscopic Submucosal Dissection Market?

Key players in the Endoscopic Submucosal Dissection Market include Olympus Corporation, Fujifilm Holdings Corporation, Medtronic plc, and Boston Scientific Corporation. Read More

What are the projected revenues for Endoscopic Submucosal Dissection with Triangulation by 2035?

The projected revenue for Endoscopic Submucosal Dissection with Triangulation is expected to reach 0.32 USD Billion by 2035. Read More

What is the expected revenue for Endoscopic Submucosal Dissection with Mucosal Flap Technique by 2035?

The expected revenue for Endoscopic Submucosal Dissection with Mucosal Flap Technique is projected to be 0.34 USD Billion by 2035. Read More

What treatment indications are driving growth in the Endoscopic Submucosal Dissection Market?

Treatment indications such as benign gastric lesions and cancer lesions are driving growth, with projected revenues of 0.25 USD Billion and 0.20 USD Billion respectively by 2035. Read More

Which endoscopic technology is anticipated to have the highest revenue by 2035?

Flexible Endoscopy is anticipated to have the highest revenue, projected to reach 0.35 USD Billion by 2035. Read More

What is the revenue outlook for High-Definition Endoscopes in the Endoscopic Submucosal Dissection Market?

The revenue outlook for High-Definition Endoscopes is expected to grow from 0.15 USD Billion in 2024 to 0.35 USD Billion by 2035. Read More

Endoscopic Submucosal Dissection Market

Q: How do revenues for Endoscopic Submucosal Dissection with Circumferential Incision compare from 2024 to 2035?

Revenues for Endoscopic Submucosal Dissection with Circumferential Incision increased from 0.12 USD Billion in 2024 to a projected 0.25 USD Billion by 2035. Read More

Endoscopic Submucosal Dissection Market Research Report By Procedure Type (Endoscopic Submucosal Dissection with Triangulation, Endoscopic Submucosal Dissection with Circumferential Incision, Endoscopic Submucosal Dissection with Mucosal Flap Technique), By Treatment Indication (Benign Esophageal Lesions, Benign Gastric Lesions, Benign Colorectal Lesions, Cancer Lesions), By Equipment Type (High-Definition Endoscope, Standard Endoscope, Single-Operator Endoscope, Multi-Operator Endoscope), By Endoscopic Technology (Narrow Band Imaging, Flexible Endoscopy, Confocal Endomicroscopy, Optical Coherence Tomography) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.17%

2024 Market Size

$ 0.42 Billion

2035 Market Size

$ 0.9 Billion

Healthcare ● Updated May 2026 Report ID: MRFR/HC/25537-HCR | Pages: 128 | Author: Nidhi Mandole, Kinjoll Dey

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Procedure Type (USD Billion)
  1. 4.1.1 Endoscopic Submucosal Dissection with Triangulation
  2. 4.1.2 Endoscopic Submucosal Dissection with Circumferential Incision
  3. 4.1.3 Endoscopic Submucosal Dissection with Mucosal Flap Technique
2. 4.2 Healthcare, BY Treatment Indication (USD Billion)
  1. 4.2.1 Benign Esophageal Lesions
  2. 4.2.2 Benign Gastric Lesions
  3. 4.2.3 Benign Colorectal Lesions
  4. 4.2.4 Cancer Lesions
3. 4.3 Healthcare, BY Equipment Type (USD Billion)
  1. 4.3.1 High-Definition Endoscope
  2. 4.3.2 Standard Endoscope
  3. 4.3.3 Single-Operator Endoscope
  4. 4.3.4 Multi-Operator Endoscope
4. 4.4 Healthcare, BY Endoscopic Technology (USD Billion)
  1. 4.4.1 Narrow Band Imaging
  2. 4.4.2 Flexible Endoscopy
  3. 4.4.3 Confocal Endomicroscopy
  4. 4.4.4 Optical Coherence Tomography
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Olympus Corporation (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fujifilm Holdings Corporation (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic plc (IE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cook Medical LLC (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Conmed Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hoya Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 EndoChoice, Inc. (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 US MARKET ANALYSIS BY TREATMENT INDICATION
5. 6.5 US MARKET ANALYSIS BY EQUIPMENT TYPE
6. 6.6 US MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
7. 6.7 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
8. 6.8 CANADA MARKET ANALYSIS BY TREATMENT INDICATION
9. 6.9 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
10. 6.10 CANADA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY TREATMENT INDICATION
14. 6.14 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
16. 6.16 UK MARKET ANALYSIS BY PROCEDURE TYPE
17. 6.17 UK MARKET ANALYSIS BY TREATMENT INDICATION
18. 6.18 UK MARKET ANALYSIS BY EQUIPMENT TYPE
19. 6.19 UK MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
20. 6.20 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY TREATMENT INDICATION
22. 6.22 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
23. 6.23 FRANCE MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
24. 6.24 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY TREATMENT INDICATION
26. 6.26 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
27. 6.27 RUSSIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
28. 6.28 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
29. 6.29 ITALY MARKET ANALYSIS BY TREATMENT INDICATION
30. 6.30 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
31. 6.31 ITALY MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
32. 6.32 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY TREATMENT INDICATION
34. 6.34 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
35. 6.35 SPAIN MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY TREATMENT INDICATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
42. 6.42 CHINA MARKET ANALYSIS BY TREATMENT INDICATION
43. 6.43 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
44. 6.44 CHINA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
45. 6.45 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
46. 6.46 INDIA MARKET ANALYSIS BY TREATMENT INDICATION
47. 6.47 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
48. 6.48 INDIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
49. 6.49 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY TREATMENT INDICATION
51. 6.51 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
52. 6.52 JAPAN MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY TREATMENT INDICATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
57. 6.57 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY TREATMENT INDICATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
60. 6.60 MALAYSIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
61. 6.61 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY TREATMENT INDICATION
63. 6.63 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
64. 6.64 THAILAND MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
65. 6.65 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY TREATMENT INDICATION
67. 6.67 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
68. 6.68 INDONESIA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
69. 6.69 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY TREATMENT INDICATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
72. 6.72 REST OF APAC MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY TREATMENT INDICATION
76. 6.76 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
77. 6.77 BRAZIL MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
78. 6.78 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY TREATMENT INDICATION
80. 6.80 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
81. 6.81 MEXICO MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
82. 6.82 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY TREATMENT INDICATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
85. 6.85 ARGENTINA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TREATMENT INDICATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TREATMENT INDICATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TREATMENT INDICATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
99. 6.99 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY TREATMENT INDICATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
102. 6.102 REST OF MEA MARKET ANALYSIS BY ENDOSCOPIC TECHNOLOGY
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY TREATMENT INDICATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY TREATMENT INDICATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY EQUIPMENT TYPE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY ENDOSCOPIC TECHNOLOGY, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY ENDOSCOPIC TECHNOLOGY, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY TREATMENT INDICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY ENDOSCOPIC TECHNOLOGY, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Endoscopic Submucosal Dissection Market Segmentation

Endoscopic Submucosal Dissection Market By Procedure Type (USD Billion, 2025-2035)

Endoscopic Submucosal Dissection with Triangulation
Endoscopic Submucosal Dissection with Circumferential Incision
Endoscopic Submucosal Dissection with Mucosal Flap Technique

Endoscopic Submucosal Dissection Market By Treatment Indication (USD Billion, 2025-2035)

Benign Esophageal Lesions
Benign Gastric Lesions
Benign Colorectal Lesions
Cancer Lesions

Endoscopic Submucosal Dissection Market By Equipment Type (USD Billion, 2025-2035)

High-Definition Endoscope
Standard Endoscope
Single-Operator Endoscope
Multi-Operator Endoscope

Endoscopic Submucosal Dissection Market By Endoscopic Submucosal Dissection Market (USD Billion, 2025-2035)

Narrow Band Imaging
Flexible Endoscopy
Confocal Endomicroscopy
Optical Coherence Tomography

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035